
Super common habit is keeping your brain awake while you sleep — even when you do it hours before bed
Late-night scrolling isn't the only thing sabotaging your slumber.
New research suggests that a common daily habit may send your brain into overdrive while you sleep — even if you do it hours before bedtime.
Scientists warn the disruption could interfere with the brain's overnight recovery processes, potentially taking a toll on your cognitive health.
4 Caffeine is a stimulant that can make it hard to fall asleep, but it might also affect your brain once you doze off.
Rido – stock.adobe.com
In the study, Canadian researchers had 40 healthy adults spend two nonconsecutive nights in a sleep lab.
On one night, participants consumed 200 milligrams of caffeine — the equivalent of about two cups of coffee — a few hours before bed. On the other, they were given a placebo.
While most people know caffeine can make it harder to fall asleep, researchers used EEG scans to track brain activity after participants dozed off and found it kept their brains in a heightened state of alertness long after they shut their eyes.
They found, for the first time, that the stimulant pushed the brain into a state of 'criticality,' making it more awake, alert and reactive than it should be while catching Zzz's.
'While this is useful during the day for concentration, this state could interfere with rest at night: the brain would neither relax nor recover properly,' said Dr. Julie Carrier, a psychology professor at the University of Montreal and co-author of the study.
4 The majority of Americans drink at least one caffeinated beverage daily.
sebra – stock.adobe.com
The team used artificial intelligence to detect subtle changes in neuronal activity and found that caffeine increased the complexity of brain signals, preventing the brain from fully powering down during sleep.
The effect was especially strong during non-REM sleep — the deep stage critical for memory and cognitive recovery.
Researchers also observed changes in brain wave patterns. Slow waves linked to deep, restorative rest were reduced, while faster waves associated with wakefulness and mental activity increased.
'These changes suggest that even during sleep, the brain remains in a more activated, less restorative state under the influence of caffeine,' said Dr. Karim Jerbi, a psychology professor at the University of Montreal and researcher at the Mila Quebec Artificial Intelligence Institute, who co-authored the study.
'This change in the brain's rhythmic activity may help explain why caffeine affects the efficiency with which the brain recovers during the night, with potential consequences for memory processing,' he added.
4 Caffeine increased neural activity during sleep and suppressed slow waves linked to deep, restorative rest.
Maryna – stock.adobe.com
Notably, the stimulant's effect's were far more pronounced in participants aged 20 to 27 compared to those aged 41 to 58 — especially during REM sleep, the dreaming phase tied to emotional and cognitive processing.
Researchers believe younger adults responded more strongly due to having more adenosine receptors. These molecules gradually accumulate in the brain throughout the day, triggering fatigue.
'Adenosine receptors naturally decrease with age, reducing caffeine's ability to block them and improve brain complexity, which may partly explain the reduced effect of caffeine observed in middle-aged participants,' Carrier said.
The findings suggest younger brains may be especially vulnerable to caffeine's hidden impact on rest.
4 Caffiene might have an event greater impact on the sleeping brain's of young people.
Svitlana – stock.adobe.com
Caffeine is the most widely consumed psychoactive drug in the world, commonly found in products such as coffee, tea, chocolate, sodas and energy drinks.
A 2023 Sleep Foundation survey found that 94% of US adults consume caffeinated beverages, and 64% drink them daily. Of those, 40% said they didn't think it affected their sleep.
While the FDA says up to 400 milligrams of caffeine per day is generally safe for healthy adults, the study suggests it could still be interfering with sleep quality — even hours after your last sip.
The scientists are calling for further research exploring how these nighttime brain changes affect day-to-day functioning and cognitive health. This, they said, could one day shape personalized caffeine recommendations.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
Psychedelics as potential mental health treatment are explored by Trump administration
The Trump administration has expressed interest in exploring psychedelics for their potential in treating PTSD and other debilitating mental health issues, various officials have shared. "The Department shares the goal of ensuring that all Americans — especially our nation's veterans — have access to safe and effective treatments for conditions such as PTSD, addiction and depression," a spokesperson for the U.S. Department of Health and Human Services (HHS), run by Sec. Robert J. Kennedy Jr., said in a statement provided to Fox News Digital. "Secretary Kennedy is committed to applying rigorous, evidence-based science to research efforts aimed at addressing these serious health challenges." Fda Approves First Ai Tool To Predict Breast Cancer Risk In recent years, researchers have been actively investigating the potential of psychedelics, such as MDMA and psilocybin ("magic mushrooms") to treat mental health disorders. MDMA is not approved for clinical use by the U.S. Food and Drug Administration (FDA), but can be studied in clinical settings. Read On The Fox News App Psilocybin is listed as a Schedule I substance under the Controlled Substances Act, which means it has "a high potential for abuse, [is not] currently accepted for medical use in treatment in the United States, and [has] a lack of accepted safety for use under medical supervision." Psilocybin-assisted therapy, however, is legal in Oregon, Colorado and New Mexico. Psychedelic medicines are "showing real promise," according to Dr. Luke Twelves, general practitioner and vice president of medical for Lindus Health in London. Clinical trials have found such treatments safe and effective for patients battling serious mental health issues, according to Twelves. Common Supplements And Medications Could Cause Liver Damage, Studies Show "Take psilocybin, for example — it's demonstrating remarkable results for severe depression that hasn't responded to other medications," he told Fox News Digital. "MDMA is showing similar breakthroughs for PTSD treatment." Clinical trials are also investigating how psychedelics could help with end-of-life anxiety, addiction, eating disorders, chronic pain and OCD, he added. Researchers have faced challenges in terms of regulatory hurdles and proper placebo controls, Twelves said. "Given that these treatments could transform [the] lives of people suffering from conditions where nothing else has worked effectively, it's crucial that we complete this research properly," he said. "The goal is to bring safe, proven psychedelic therapies to the patients who need them most." At President Trump's May 1 cabinet meeting, Department of Veterans Affairs Secretary Doug Collins said that "we're opening up the possibility of psychedelic treatment." Retired Army Sergeant Jonathan Lubecki recently told Fox News' Alexandria Hoff that MDMA stopped his PTSD while he was participating in a clinical trial. "[I] took my first dose of MDMA. I've only taken it three times as part of the clinical trial, haven't taken it since, and haven't found the need to take it since, because I haven't had PTSD," he said. Peter Kasperowicz, Department of Veterans Affairs press secretary, told Fox News Digital the department is safely exploring all avenues that promote the health of veterans. Fallujah Vet Turns Medal Of Heroism Into A Healing Mission For Fellow Warriors With Service Dogs Program "Preliminary findings have produced positive results on psychedelic-assisted therapies for treating mental health conditions," he said. The VA is currently running 11 clinical trials in various phases, with a total of some 800 veterans expected to participate. "The goal of these trials is to determine whether compounds such as MDMA and psilocybin can treat veterans with post-traumatic stress disorder, treatment-resistant depressive disorder, major depressive disorder and potentially other mental health conditions," said Kasperowicz. An MDMA study published in the Jan. 2025 issue of The American Journal of Psychiatry found that the substance is "unlike classical psychedelics." The study noted, "MDMA allows the individual to maintain intact ego functioning and a greater degree of cognitive and perceptual lucidity while still experiencing a prosocial altered state of consciousness that facilitates deeply emotional therapeutic breakthroughs." Click Here To Sign Up For Our Health Newsletter The researchers concluded that MDMA showed "enhanced levels of trust, empathy, self-compassion and a 'window of tolerance'" that traditional psychotherapy lacks. Doug Drysdale, CEO of the Canadian pharmaceutical company Cybin, told Fox News Digital that "the time is now to address the mental health crisis." He said it is "gratifying" that administration officials value the potential benefits of looking into alternative mental health treatments. Cybin is currently in phase 3 of a study of CYB003, a type of psilocybin that has been granted breakthrough therapy designation by the FDA as an additional treatment for major depressive disorder (MDD). "In Cybin's completed Phase 2 MDD study, long-term efficacy results showed that 71% of participants were in remission from depression, and 100% of participants responded to treatment at 12 months after just two 16 mg doses of CYB003," said Drysdale. Dr. Marc Siegel, clinical professor of medicine at NYU Langone Medical Center and Fox News' senior medical analyst, previously interviewed two of the country's top researchers on psychedelics — Dr. Rachel Yehuda, founder and director of the Center for Psychedelic Psychotherapy and Trauma Research at Mt. Sinai in New York, and Dr. Charles Marmar, director of the PTSD research program at NYU Langone. "They agree there is therapeutic potential if very carefully studied under very strict medical guidance, but there is a huge downside in terms of unregulated recreational uses," Siegel told Fox News Digital at the time. "Both doctors see likely therapeutic value to psychedelics if carefully managed by medical experts," Siegel added. Ryan Moss, chief science officer at Filament Health, a clinical-stage natural psychedelic drug development company in Canada, emphasized it's important to administer psychedelics in a safe setting when treating mental health conditions. For more Health articles, visit "Psychedelic experiences can sometimes feature anxiety, hallucinations and paranoia," Moss previously told Fox News Digital. "Some patients using traditional psychedelics have reported experiencing adverse cardiovascular events during clinical trials." To mitigate these risks, Moss recommended clinical trial participants receive thorough preparation and monitoring by trained professionals during sessions. Melissa Rudy and Angelica Stabile, both of Fox News Digital, contributed article source: Psychedelics as potential mental health treatment are explored by Trump administration


Newsweek
2 hours ago
- Newsweek
One Million Drivers Told To Avoid Gas Stations
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Indiana residents are being advised to minimize visits to gas stations today as smoke from Canadian wildfires continues to worsen air quality across the state. The Indiana Department of Environmental Management (IDEM) has extended an Air Quality Action Day through Saturday; fine particulate levels are reaching unhealthy thresholds, particularly in northern, northeastern, and northwestern regions, as reported by WNDU, potentially affecting at least a million people. Newsweek contacted IDEM for comment via email on Saturday. Why It Matters EPA reports that Volatile Organic Compounds (VOCs) are chemicals that easily evaporate into the air and are released from sources like petrol stations, vehicle exhaust, paints, and industrial processes. At gas stations, VOCs escape during refueling and contribute to air pollution even with vapor recovery systems in place. When VOCs react with nitrogen oxides (NOx) in sunlight, they form ground-level ozone—a major component of smog, the United States Environmental Protection Agency reports. EPA advises that this ozone can aggravate asthma, trigger respiratory symptoms, and harm people with existing heart or lung conditions. File photo: The price of gasoline is displayed on a pump at a gas station on March 6, 2025 in Chicago, Illinois. File photo: The price of gasoline is displayed on a pump at a gas station on March 6, 2025 in Chicago, To Know The smoke originates from over 200 wildfires burning across Canada, as reported by the Canadian Interagency Forest Fire Center, with plumes stretching thousands of miles and affecting air quality throughout the U.S. Midwest. In some areas, air-quality indexes have reached levels deemed "very unhealthy," prompting widespread advisories. Reducing vehicle emissions can help mitigate ozone formation during such alerts. Residents are encouraged to limit driving, avoid refueling vehicles during daylight hours, and postpone the use of gasoline-powered equipment. To reduce pollution and protect public health, it is recommended to avoid gas stations during air-quality alerts or refueling in the evening, when ozone formation is less likely. As reported by Newsweek, at least two people have died and tens of thousands have been evacuated in Canada as a result of the blazes. WDNU reported that the following cities in Indiana will be most affected by the air quality: North Central Indiana: Including the cities of Elkhart, Goshen, Knox, Logansport, Plymouth, Peru, South Bend, Warsaw, Winamac, and all other cities within the area. Northeast Indiana: Including the cities of: Angola, Auburn, Decatur, Fort Wayne, Hartford, Huntington City, LaGrange, Marion, Portland, Wabash and all other cities within the area. Northwest Indiana: Including the cities of: Crown Point, Gary, Hammond, Kentland, LaPorte, Michigan City, Portage, Rensselaer, Valparaiso, and all other cities within the area. IDEM has issued some recommended actions that the public can take. These include: Walk, bike, carpool or use public transportation. Avoid using the drive-through and combine errands into one trip. Avoid refueling your vehicle or using gasoline-powered lawn equipment until after 7 p.m. Turn off your engine when idling for more than 30 seconds. Conserve energy by turning off lights or setting the air conditioner to 75 degrees Fahrenheit or above. A National Weather Service (NWS) air quality alert said that fine particulate levels are expected to be in the Unhealthy for Sensitive Groups range. Active children and adults, and people with respiratory disease, such as asthma, should limit prolonged outdoor exposure. What People Are Saying The American Lung Association warns that wildfire smoke poses significant health risks, especially for children, older adults, and individuals with respiratory conditions. They recommend staying indoors, using air purifiers, and keeping windows closed to reduce exposure. The American Lung Association stated on its website: "Areas throughout the Midwest, including parts of Indiana, will see their air quality impacted by smoke from wildfires burning in Canada this weekend. The smoke is prompting several communities to issue air-quality alerts. "It is unhealthy to breathe and can be especially harmful to sensitive groups, including children, older adults, and people with lung diseases like asthma and chronic obstructive pulmonary disease." What Happens Next Residents are advised to monitor local air-quality reports and take necessary precautions to protect their health during this period of elevated pollution.
Yahoo
4 hours ago
- Yahoo
Opinion - How thousands of unreviewed ingredients got into our food — and what FDA can do about it
At least 1,000 ingredients in food products on our grocery store shelves have never been checked for safety by the Food and Drug Administration. Dozens have raised serious safety concerns among experts. How did the FDA allow this? The answer can be found in the agency's lax interpretation of a little-known legal designation that lets companies decide for themselves if ingredients in their products are safe. Fortunately, there are steps the agency can take right now to stem the flow of potentially unsafe ingredients into our food supply. Environmental Defense Fund outlined these steps in a letter we recently sent to the agency, but first let's take a closer look at how we got here. 'Generally Recognized as Safe' is a designation Congress created in 1958 to allow commonly used food ingredients to bypass the FDA's pre-market safety review process. It was meant for food substances — such as oils, vinegar, baking soda and common spices — that were widely considered safe due to their long history of everyday use. Since 1958, this status has been coopted to cover a universe of foods that extends far beyond its original intent. According to FDA regulations, a chemical can receive the designation if experts widely agree that scientific evidence shows its use to be safe. But because 'Generally Recognized as Safe' wasn't meant for newer ingredients, Congress allowed ingredients so designated to skip the FDA's premarket approval process — despite requiring similar evidence for other additives. Under the agency's current interpretation, companies can designate the use of a substance as safe and take products with that substance to market without informing the FDA or the public of its decision. While companies may voluntarily submit a notice to FDA offering safety evidence, they are not required to — and often don't. Our organization estimated that manufacturers have notified FDA of fewer than half of the ingredients they market as safe under the 'Generally Recognized' standard. Companies that do bother to submit a notice to the FDA are free to withdraw it at any point and take their product to market, provided they can cite evidence of its safe use. But this 'evidence' is often far from independent. Companies can, and often do, enlist their own employees or handpicked consultants to conduct their safety assessments. The result is a process riddled with conflicts of interest that lets unsafe foods into Americans' homes. We analyzed 'Generally Recognized as Safe' notices received by the FDA, obtained via a Freedom of Information request, and found that of the 1,163 submitted by companies between 1997 and April 2024, 192 were later withdrawn, with safety concerns cited in at least a dozen cases. We also identified 31 ingredients that companies have advertised to be recognized as safe, such as in press releases, trade publications and on their own websites (see the Appendix of our letter). However, we were unable to find the scientific evidence required under this standard to demonstrate these ingredients are commonly regarded as safe among experts. This raises red flags that FDA should be taking seriously. Although a comprehensive fix to the 'Generally Recognized' standard will require legislation from Congress, there are significant steps the FDA can take right away to ensure a more rigorous determination process that better protects Americans' health. Starting today, the FDA can use existing authority to remove safe designations from ingredients it deems unsafe and take them off the market. It can also notify manufacturers, importers, distributors and retailers that the substance is no longer recognized as safe. In addition, the FDA can enforce the requirement that companies base safety designations on publicly available data. Although this won't curtail companies' ability to self-declare substances as safe, it will require those who do to be transparent in citing their evidence. Third, the FDA can enforce the requirement that safety assessments consider vital health information such as a substance's dietary sources, potential cancer risks and the cumulative health effects of similar substances. Finally, the FDA can make companies revise and resubmit their data for review when they submit 'Generally Recognized as Safe' notices that fail to comply with the criteria. The 'Generally Recognized as Safe' designation is far from a perfect system, but it can work better if it is interpreted and enforced more comprehensively. If the FDA is serious about protecting public health, it should start by fully exercising the tools already at its disposal. Maria Doa is senior director at the Chemicals Policy at Environmental Defense Fund. Maricel Maffini is an independent consultant focused on human and environmental health and chemical safety. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.